Advertisement
Home »

How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?

Aug 07, 2023

ABOUT THE EXPERTS

  • Nader Hejrati

    Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

    Division of Neurosurgery and Spine Program, Department of Surgery, University of Toronto, Toronto, ON, Canada.

    Raymond Wong

    Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

    Mohamad Khazaei

    Division of Neurosurgery and Spine Program, Department of Surgery, University of Toronto, Toronto, ON, Canada.

    Michael G Fehlings

    Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

    Division of Neurosurgery and Spine Program, Department of Surgery, University of Toronto, Toronto, ON, Canada.

    Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement